Loading...
Underutilized Pharma Services And Execution Risks Will Threaten Demand Yet Efficiency Will Emerge
AnalystLowTarget's Fair Value
US$6.50
40.0% overvalued intrinsic discount28 Aug
US$9.10
1Y
-34.1%7D
0%1Y
-34.1%7D
0%You can edit this narrative until Aug 7 10:29 PM. Then, changes will post as Updates.